Lih‐Jen Su
Impact in
- Biochemistry top 5%
- Sulfur Compounds in Biology
- Pharmacology top 5%
- Berberine and alkaloids research
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Synthesis and bioactivity of alkaloids 4
-
- Prostate Cancer Treatment and Research 4
- Silymarin and Mushroom Poisoning 4
- Co-authors
- Thomas W. Flaig (18 shared papers)Gail S. Harrison (4 shared papers)Rajesh Agarwal (3 shared papers)L. Michael Glodé (7 shared papers)Daniel L. Gustafson (3 shared papers)Joseph A. Zirrolli (1 shared paper)A. Scott Pierson (1 shared paper)Frances Crighton (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Dermatological Science (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Investigational New Drugs (1 paper)The Prostate (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Lih‐Jen Su
25 papers receiving 954 citations
Peers
Comparison fields: 5 of 93
- Biochemistry 118
- Pharmacology 101
- Pulmonary and Respiratory Medicine 359
- Cancer Research 154
- Pharmacology 137
Countries citing papers authored by Lih‐Jen Su
This map shows the geographic impact of Lih‐Jen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lih‐Jen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lih‐Jen Su more than expected).
Fields of papers citing papers by Lih‐Jen Su
This network shows the impact of papers produced by Lih‐Jen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lih‐Jen Su. The network helps show where Lih‐Jen Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Lih‐Jen Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 264 | |
| 2 | 2010 | 148 | |
| 3 | 1990 | 112 | |
| 4 | 2017 | 73 | |
| 5 | 2007 | 50 | |
| 6 | 1999 | 48 | |
| 7 | 2018 | 38 | |
| 8 | 2001 | 35 | |
| 9 | 2014 | 32 | |
| 10 | 2009 | 25 | |
| 11 | 2011 | 21 | |
| 12 | 1997 | 17 | |
| 13 | 2002 | 15 | |
| 14 | 2013 | 14 | |
| 15 | 2003 | 12 | |
| 16 | 2017 | 12 | |
| 17 | 2006 | 12 | |
| 18 | 1995 | 11 | |
| 19 | 2024 | 10 | |
| 20 | 2005 | 10 |
About Lih‐Jen Su
Lih‐Jen Su is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Biotechnology, Cancer Research and Surgery, having authored 26 papers that have together received 975 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Nanoplatforms for cancer theranostics (4 papers), Cancer, Lipids, and Metabolism (4 papers), Synthesis and bioactivity of alkaloids (4 papers), Prostate Cancer Treatment and Research (4 papers), Cancer-related Molecular Pathways (4 papers), Silymarin and Mushroom Poisoning (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Biochemistry (118 citations), Pharmacology (101 citations), Pulmonary and Respiratory Medicine (359 citations), Cancer Research (154 citations) and Pharmacology (137 citations). Lih‐Jen Su has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Thomas W. Flaig, Gail S. Harrison, Rajesh Agarwal, L. Michael Glodé, Daniel L. Gustafson, Joseph A. Zirrolli, A. Scott Pierson, Frances Crighton, L. Michael Glode and Paul F. Erickson. Their work appears in journals such as Journal of Clinical Oncology, Journal of Dermatological Science, JNCI Journal of the National Cancer Institute, Investigational New Drugs and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.